National Health Investors (NYSE:NHI) Stock Price Passes Above 200-Day Moving Average – Time to Sell?

National Health Investors, Inc. (NYSE:NHI)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $75.36 and traded as high as $77.40. National Health Investors shares last traded at $77.2470, with a volume of 173,949 shares changing hands.

Analyst Ratings Changes

NHI has been the subject of a number of research analyst reports. Cantor Fitzgerald initiated coverage on shares of National Health Investors in a research report on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 price target for the company. Truist Financial upped their price objective on shares of National Health Investors from $81.00 to $83.00 and gave the company a “buy” rating in a research note on Monday, December 15th. Wells Fargo & Company increased their target price on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th. KeyCorp lifted their target price on shares of National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of National Health Investors in a report on Monday, December 22nd. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $87.33.

National Health Investors Stock Performance

The company has a debt-to-equity ratio of 0.74, a quick ratio of 10.64 and a current ratio of 10.64. The company has a market cap of $3.68 billion, a P/E ratio of 24.37, a P/E/G ratio of 2.99 and a beta of 0.68. The firm has a 50 day moving average price of $77.10 and a 200-day moving average price of $75.36.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.08. National Health Investors had a return on equity of 10.17% and a net margin of 41.38%.The business had revenue of $83.36 million for the quarter, compared to the consensus estimate of $85.66 million. During the same period last year, the business earned $1.03 EPS. The firm’s revenue was down 1.8% compared to the same quarter last year. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, research analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be paid a $0.92 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $3.68 dividend on an annualized basis and a yield of 4.8%. National Health Investors’s dividend payout ratio (DPR) is presently 116.09%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. JPMorgan Chase & Co. grew its position in shares of National Health Investors by 305.2% in the second quarter. JPMorgan Chase & Co. now owns 1,203,492 shares of the real estate investment trust’s stock valued at $84,389,000 after purchasing an additional 906,479 shares during the last quarter. Norges Bank bought a new position in National Health Investors in the 2nd quarter worth approximately $49,775,000. M Holdings Securities Inc. bought a new position in National Health Investors in the 2nd quarter worth approximately $36,607,000. Balyasny Asset Management L.P. lifted its holdings in shares of National Health Investors by 66.9% during the second quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock worth $43,121,000 after buying an additional 246,486 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of National Health Investors by 481.3% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 236,383 shares of the real estate investment trust’s stock valued at $18,792,000 after acquiring an additional 195,716 shares during the period. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.